Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision label on the page updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a minor system update. The change does not modify study details, eligibility criteria, or other substantive content on the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision stamp updated from v3.6.4 to v3.6.5, signaling a routine platform update. The study page content and visible information appear unchanged.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a minor page refresh rather than a change to study content.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry appears, updating the platform version to v3.6.3 and removing the previous v3.6.2 from the revision history.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page displays Revision: v3.6.2, replacing the prior v3.6.0. This is a routine version update that does not modify the study details or what users see on the page.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, plus a new revision tag (Revision: v3.6.0); older labels such as 'Verified' and 'Last known status was:' are removed.SummaryDifference1%

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.